175 related articles for article (PubMed ID: 33589432)
1. G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma.
Kelly GM; Al-Ejeh F; McCuaig R; Casciello F; Ahmad Kamal N; Ferguson B; Pritchard AL; Ali S; Silva IP; Wilmott JS; Long GV; Scolyer RA; Rao S; Hayward NK; Gannon F; Lee JS
Clin Cancer Res; 2021 May; 27(9):2624-2635. PubMed ID: 33589432
[TBL] [Abstract][Full Text] [Related]
2. G9a inhibition induced PKM2 regulates autophagic responses.
Ahmad F; Dixit D; Joshi SD; Sen E
Int J Biochem Cell Biol; 2016 Sep; 78():87-95. PubMed ID: 27417236
[TBL] [Abstract][Full Text] [Related]
3. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
4. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
Colyn L; Bárcena-Varela M; Álvarez-Sola G; Latasa MU; Uriarte I; Santamaría E; Herranz JM; Santos-Laso A; Arechederra M; Ruiz de Gauna M; Aspichueta P; Canale M; Casadei-Gardini A; Francesconi M; Carotti S; Morini S; Nelson LJ; Iraburu MJ; Chen C; Sangro B; Marin JJG; Martinez-Chantar ML; Banales JM; Arnes-Benito R; Huch M; Patino JM; Dar AA; Nosrati M; Oyarzábal J; Prósper F; Urman J; Cubero FJ; Trautwein C; Berasain C; Fernandez-Barrena MG; Avila MA
Hepatology; 2021 Jun; 73(6):2380-2396. PubMed ID: 33222246
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of autophagy by the methyltransferase G9a.
Artal-Martinez de Narvajas A; Gomez TS; Zhang JS; Mann AO; Taoda Y; Gorman JA; Herreros-Villanueva M; Gress TM; Ellenrieder V; Bujanda L; Kim DH; Kozikowski AP; Koenig A; Billadeau DD
Mol Cell Biol; 2013 Oct; 33(20):3983-93. PubMed ID: 23918802
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.
Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R
Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma.
Ren A; Qiu Y; Cui H; Fu G
Biochem Biophys Res Commun; 2015 Mar; 459(1):10-7. PubMed ID: 25634693
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma.
Li KC; Hua KT; Lin YS; Su CY; Ko JY; Hsiao M; Kuo ML; Tan CT
Mol Cancer; 2014 Jul; 13():172. PubMed ID: 25027955
[TBL] [Abstract][Full Text] [Related]
9. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
[No Abstract] [Full Text] [Related]
10. Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
Zhou M; Zhang X; Liu C; Nie D; Li S; Lai P; Jin Y
Oncogene; 2021 May; 40(20):3564-3577. PubMed ID: 33931742
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.
Cao YP; Sun JY; Li MQ; Dong Y; Zhang YH; Yan J; Huang RM; Yan X
Acta Pharmacol Sin; 2019 Aug; 40(8):1076-1084. PubMed ID: 30765842
[TBL] [Abstract][Full Text] [Related]
12. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.
Irifuku T; Doi S; Sasaki K; Doi T; Nakashima A; Ueno T; Yamada K; Arihiro K; Kohno N; Masaki T
Kidney Int; 2016 Jan; 89(1):147-57. PubMed ID: 26444031
[TBL] [Abstract][Full Text] [Related]
14. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
[TBL] [Abstract][Full Text] [Related]
15. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M
Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511
[TBL] [Abstract][Full Text] [Related]
16. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation.
Ding J; Li T; Wang X; Zhao E; Choi JH; Yang L; Zha Y; Dong Z; Huang S; Asara JM; Cui H; Ding HF
Cell Metab; 2013 Dec; 18(6):896-907. PubMed ID: 24315373
[TBL] [Abstract][Full Text] [Related]
17. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
[TBL] [Abstract][Full Text] [Related]
18. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
[TBL] [Abstract][Full Text] [Related]
19. Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.
Liu CW; Hua KT; Li KC; Kao HF; Hong RL; Ko JY; Hsiao M; Kuo ML; Tan CT
Mol Cancer Ther; 2017 Jul; 16(7):1421-1434. PubMed ID: 28265008
[TBL] [Abstract][Full Text] [Related]
20. Druggable epigenetic suppression of interferon-induced chemokine expression linked to
Seier JA; Reinhardt J; Saraf K; Ng SS; Layer JP; Corvino D; Althoff K; Giordano FA; Schramm A; Fischer M; Hölzel M
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
